Ownership history in MORGAN STANLEY · 6 quarters on record
This page tracks every 13F SEC filing in which MORGAN STANLEY reported a position in SUNSHINE BIOPHARMA INC (SBFM). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 14,634 | +10,800 | +281.7% | 0.00% | $18K | $1.23 |
| 2025 Q3 | UNCHANGED | 3,834 | — | 0% | 0.00% | $6K | $1.49 |
| 2025 Q2 | UNCHANGED | 3,834 | — | 0% | 0.00% | $6K | $1.44 |
| 2025 Q1 | REDUCED | 3,834 | -3,806 | -49.8% | 0.00% | $7K | $1.91 |
As of 2025 Q4 — sorted by position size